Gareth Robinson

Dr. Gareth Robinson serves as Associate Director of Planning and Partnerships within the Department of Applied Sciences at the University of the West of England's Faculty of Health and Applied Sciences. Holding a PhD and FHEA (Fellow of the Higher Education Academy), he maintains an active research profile while fulfilling administrative responsibilities. His dual role bridges academic research and institutional planning within the university's health sciences framework.

Dr. Robinson's research program centers on bacterial bioluminescence applications, with particular expertise in genetic modification of human pathogens using plasmid-borne bacterial lux genes. His work has established innovative methodologies for monitoring antibiotic efficacy, conducting transcytosis and invasion assays with human cell lines, and evaluating novel biocide technologies including non-thermal plasma and aerosol delivery systems.

• Specializes in developing bioluminescent reporter strains as whole-cell bioreporters
• Focuses on real-time monitoring of antimicrobial activity in situ
• Investigates leukemia treatment resistance mechanisms using bioluminescent biosensors
• Contributes to water safety research through biofiltration studies

His publication record demonstrates consistent scholarly output from 2009 through 2025, with recent work expanding into avian influenza impacts on animal populations and advanced leukemia research. Dr. Robinson's interdisciplinary approach bridges microbiology, oncology, and environmental science, particularly through his development of bioluminescent biosensors for real-time monitoring applications. His collaborative work appears across multiple journals and conference presentations, reflecting engagement with both clinical and environmental microbiology communities.

While specific awards aren't documented in the available information, Dr. Robinson's research has generated substantial scholarly output with practical applications in healthcare disinfection, antimicrobial testing, and cancer treatment research. His work on electrochemically activated solutions and nonthermal plasma technologies represents significant contributions to biocide development and evaluation methodologies.

Dr. Robinson's research program demonstrates strong connections between laboratory science and practical applications, particularly in developing rapid detection methods for biocide efficacy and investigating mechanisms of chemotherapy resistance in leukemia. His work with bioluminescent reporter strains provides valuable tools for real-time monitoring in both clinical and environmental contexts. The Department of Applied Sciences at UWE Bristol serves as the institutional home for his multifaceted research program that spans medical microbiology, biocidal technologies, and cancer research applications.